• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Bio-Reference Laboratories Inc. (BRLI)

    -NasdaqGS
    35.23 Up 0.22(0.63%) Apr 24, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Bio-Reference Laboratories Inc.
    481 Edward H. Ross Drive
    Elmwood Park, NJ 07407
    United States - Map
    Phone: 201-791-2600
    Website: http://www.bioreference.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Laboratories & Research
    Full Time Employees:3,406

    Business Summary 

    Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases in the United States. The company focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. It offers chemical diagnostic tests, such as blood and urine analysis; blood chemistry; hematology services; serology; radio-immuno analysis; toxicology, including drug screening; pap smears; tissue pathology comprising biopsies; and other tissue analysis, as well as cancer cytogenetic testing, genetic testing, and cytology testing services. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. It serves physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is headquartered in Elmwood Park, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Bio-Reference Laboratories Inc.

    Corporate Governance 
    Bio-Reference Laboratories Inc.’s ISS Governance QuickScore as of Apr 1, 2015 is 8. The pillar scores are Audit: 5; Board: 10; Shareholder Rights: 7; Compensation: 2.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Dr. Marc D. Grodman M.D., 63
    Founder, Chairman, Chief Exec. Officer, Pres and Managing Director
    1.47M0.00
    Mr. Sam Singer , 71
    Chief Financial Officer, Chief Accounting Officer, Sr. VP and Director
    500.00K0.00
    Mr. Howard Dubinett , 63
    Chief Operating Officer, Exec. VP and Director
    504.00K0.00
    Mr. Richard L. Faherty , 68
    Chief Information Officer and Sr. VP of Corp. Affairs, Interoperability & Communications
    N/AN/A
    Ms. Wendy Chung ,
    Chief Scientific Officer
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders